Table 3.

The locally advanced group outcome as a function of the primary goal of RAI administration (therapeutic vs. adjuvant)

No. of patients	D-Rx				E-Rx
	RAI therapy for known persistent disease [5/14 (35.7%)]		Adjuvant therapy for suspected disease [9/14 (64.3%)]		RAI therapy for known persistent disease [13/30 (43.3%)]		Adjuvant therapy for suspected disease [17/30 (56.6%)]
	Central neck uptake	Lateral neck uptake	Central neck uptake	Lateral neck uptake	Central neck uptake	Lateral neck uptake	Central neck uptake	Lateral neck uptake
Total	4	1	5	4	10	3	11	6
CR	2	0	3	0	0	0	1	0
SD	2	1	2	3	9	2	6	6
PD	0	0	0	1	1	1	4	0